Patent application number | Description | Published |
20080261948 | Ligands for G-Protein Coupled Receptors - The invention provides compounds of general formulae I-IV or pharmaceutically acceptable salts thereof: | 10-23-2008 |
20090036486 | COMPOSITION - The invention relates to the use of 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one for preparing a medicament intended to prevent or treat inflammatory disorders. | 02-05-2009 |
20090203739 | Anti-Inflammatory Agents - The invention provides compounds, pharmaceutical compositions and uses of compounds of general formula (I) or a pharmaceutically acceptable salt thereof, for the preparation of a medicament intended to treat an inflammatory disorder; wherein z X is 1, 2 or 4; X is —CO—Y | 08-13-2009 |
20100016286 | Anti-Inflammatory Agents - The invention provides compounds, pharmaceutical compositions and uses of compounds and salts thereof of general formula (I), for the preparation of a medicament for treatment of an inflammatory disorder, but excluding (S)-3-(r-methylcyclohexyl-carbonylamino)-caprolactam: wherein z is 1, 2, 3 or 4; A is —CO— or —SO2-; Q is linear or branched alkyl, alkenyl, alkynyl, alkoxy, oxyalkyl, aminoalkyl, alkylamino, alkylaminoalkyl, haloalkyl, aryl or substituted aryl; T | 01-21-2010 |
20110003792 | ANTI-INFLAMMATORY AGENTS - The invention provides compounds, pharmaceutical compositions and uses of compounds and salts thereof of general formula (I), for the preparation of a medicament for treatment of an inflammatory disorder, | 01-06-2011 |
20120046198 | Ligand Libraries for Screening GPCRs - The invention provides compounds of general formulae (I)-(IV) or pharmaceutically acceptable salts thereof: | 02-23-2012 |
20130172319 | Alpha-AminoCycloLactam Ligands for G-Protein Coupled Receptors, and Methods of Using Same - The invention relates to the generation of a library of compounds enriched in agonist and antagonists for members of the G-protein coupled class of receptors (GPCRs). | 07-04-2013 |
20130203734 | ANTI-INFLAMMATORY AGENTS - Disclosed herein are methods of preventing or treating inflammatory diseases using sulfonamide analogs of 3-aminolactam compounds, each with aromatic “tail groups”. Compounds as defined by formulae (I) and (I′), and the medical uses of the compounds, are described herein. | 08-08-2013 |
20140336227 | 3-AMINO LACTAMS AS ANTI-INFLAMMATORY AGENTS - Compounds, pharmaceutical compositions of general formula (I) or (I′) or a pharmaceutically acceptable salt thereof, and methods for treating an inflammatory disorder: | 11-13-2014 |
Patent application number | Description | Published |
20080227724 | Anti-Inflammatory Agents - The invention relates to the use of 3-aminocaprolactam derivatives for preparing a medicament intended to prevent or treat inflammatory disorders, and uses compounds of general formula (I) or a pharmaceutically acceptable salts thereof; | 09-18-2008 |
20100113518 | METHODS OF USING ANTI-INFLAMMATORY COMPOUNDS - The invention relates to the use of 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one for preparing a medicament intended to prevent or treat inflammatory disorders. | 05-06-2010 |
20100292213 | Anti-Inflammatory Agents - The invention provides compounds, compositions and uses of compounds of general formula (I) or pharmaceutically acceptable salts thereof, which are 3-aminocaprolactam derivatives, for the preparation of a medicament intended to treat an inflammatory disorder: | 11-18-2010 |
20110288073 | Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same - The invention relates to the generation of a library of compounds enriched in agonist and antagonists for members of the G-protein coupled class of receptors (GPCRs). | 11-24-2011 |